Search

Lexicon Pharmaceuticals Inc

Fermé

SecteurSoins de santé

1.81 -1.09

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.81

Max

1.83

Chiffres clés

By Trading Economics

Revenu

-32M

-33M

Ventes

-20M

692K

BPA

-0.06

Marge bénéficiaire

-4,742.486

Employés

81

EBITDA

-30M

-29M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+217.31% upside

Dividendes

By Acuity

Prochains Résultats

5 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-190M

845M

Ouverture précédente

2.9

Clôture précédente

1.81

Sentiment de l'Actualité

By Acuity

67%

33%

265 / 340 Classement par Healthcare

Lexicon Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 oct. 2026, 22:45 UTC

Lexicon Pharmaceuticals Inc declined in after-market trading, moving lower since Friday's close, amid broader market weakness and volatility.

1 oct. 2026, 20:07 UTC

Lexicon Pharmaceuticals Inc. shares fell sharply, continuing a decline since Wednesday and trading below the 20-day moving average near the lower end of its one-month range.

30 sept. 2026, 20:12 UTC

Lexicon Pharmaceuticals Inc. is trading lower in after-market hours, continuing a downward trend and positioned significantly below its 20-day moving average.

29 sept. 2026, 22:31 UTC

Lexicon Pharmaceuticals Inc has advanced significantly in after-market trading, now about 4% below its 20-day moving average following Tuesday's close.

28 sept. 2026, 22:01 UTC

News

Lexicon Pharmaceuticals Inc is up in after-market trading after Cantor Fitzgerald initiated coverage with an "overweight" rating and an $8 price target.

25 sept. 2026, 23:55 UTC

Lexicon Pharmaceuticals Inc is rising in after-market trading, gaining ground since Friday's close, marking a notable divergence from four consecutive sessions of losses.

24 sept. 2026, 20:01 UTC

Lexicon Pharmaceuticals Inc shares fell sharply, reversing a trend of higher daily closes amid a broader market context of diverging momentum.

23 sept. 2026, 20:07 UTC

Lexicon Pharmaceuticals Inc shares fell sharply, finishing significantly lower on Wednesday, hitting a low around midday before a slight late-session recovery.

22 sept. 2026, 20:01 UTC

Lexicon Pharmaceuticals Inc is gaining strength during Tuesday's session, reaching a peak earlier before pulling back slightly while remaining below its 20-day moving average.

21 sept. 2026, 20:40 UTC

Lexicon Pharmaceuticals Inc is declining in after-market trading, influenced by a drop in the Chicago Fed National Activity Index and broader market trends.

16 sept. 2026, 20:10 UTC

Macro Event

Lexicon Pharmaceuticals Inc is advancing, continuing a modest upward trend since Tuesday, amid sensitivity to macroeconomic developments following the Fed's interest rate hike.

11 sept. 2026, 20:08 UTC

Lexicon Pharmaceuticals Inc. shares are lower today, continuing a decline since Thursday's close. Earlier, the stock peaked before reversing course during routine fluctuations.

10 sept. 2026, 19:21 UTC

News

Lexicon Pharmaceuticals is lower today, continuing a five-session decline amid broader market pressures following the European Central Bank's interest rate hike.

8 sept. 2026, 20:07 UTC

Lexicon Pharmaceuticals shares are lower today, following a strong jobs report that raised interest rate hike speculation. The stock remains below its 20-day moving average.

5 sept. 2026, 00:00 UTC

Lexicon Pharmaceuticals Inc shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics and strong labor market data.

3 sept. 2026, 19:26 UTC

Lexicon Pharmaceuticals Inc is higher today, with no specific news identified. Broader market declines in Treasury yields may be influencing trading.

24 août 2026, 19:36 UTC

News

Lexicon Pharmaceuticals received a $10 million milestone payment from Novo Nordisk, bringing total payments to $75 million as shares rise during Monday's session.

21 août 2026, 19:36 UTC

Lexicon Pharmaceuticals Inc shares are higher in Friday's session, continuing an upward trend since Thursday. The stock remains below its 20-day moving average.

20 août 2026, 23:56 UTC

Lexicon Pharmaceuticals Inc shares are rising in after-market trading, showing positive momentum despite being below their 20-day moving average. No specific news was identified.

18 août 2026, 19:31 UTC

Lexicon Pharmaceuticals Inc shares are higher today, driven by significant gains in the Biotechnology sub-sector. The stock is near its one-month high.

13 août 2026, 19:56 UTC

Lexicon Pharmaceuticals is trading lower today amid no specific news. First-time claims for U.S. unemployment benefits rose, but investor sentiment remains stable.

12 août 2026, 23:36 UTC

Lexicon Pharmaceuticals Inc's shares are higher in after-market trading, with no specific news identified. Broader market sentiment may be influenced by recent inflation data.

11 août 2026, 23:26 UTC

Lexicon Pharmaceuticals Inc. shares are lower in after-market trading, with no specific news identified. Broader market sentiment remains cautious amid oil price developments.

10 août 2026, 19:56 UTC

News

Lexicon Pharmaceuticals reported a second-quarter earnings loss of -$0.06 per share, missing expectations. Shares are lower amid a downgrade to “sell” from Wall Street Zen.

7 août 2026, 22:01 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours, continuing a notable decline since Friday's close, with no specific news identified to explain the movement.

6 août 2026, 23:26 UTC

Lexicon Pharmaceuticals shares are trading higher in after-market hours, following three consecutive sessions of declines. No specific news was identified for the price movement.

5 août 2026, 19:36 UTC

News

Lexicon Pharmaceuticals Inc shares are lower as investors adjust positions ahead of Q2 earnings on August 5, with consensus EPS estimates at -$0.05.

4 août 2026, 19:56 UTC

Lexicon Pharmaceuticals shares are higher today, reflecting strong momentum amid easing inflation concerns from declining crude oil prices. No specific news was identified.

31 juil. 2026, 19:46 UTC

Lexicon Pharmaceuticals Inc shares are lower today, reflecting broader market trends amid rising yields and crude oil prices contributing to inflation concerns.

30 juil. 2026, 23:11 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours. The decline follows broader market uncertainty after the Federal Reserve's interest rate decision.

Comparaison

Variation de prix

Lexicon Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

217.31% hausse

Prévisions sur 12 Mois

Moyen 5.775 USD  217.31%

Haut 8 USD

Bas 3.1 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

4

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

265 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.